Here we demonstrate that first, Winked carbohydrate on the lateral surface of Va blocks the interaction of the TCR V(3 with the self superantigen, Mls-1', but has no effect on the TCR interaction with peptide antigen and MHC, second, that the interaction site for Mls-1' extends over the surface of the solvent-exposed /3-pleated sheet on the side of the TCR, and third, that mutations which affect both superantigen and peptide antigen reactivity lie at the beginning of the first complementarity determining region of VA consistent with models of the trimolecular complex of TCR-peptide-MHC
.2
for . A panel of T cell hybridomas expressing mutant V08 .2 elements were tested for their responses to Mls-1', as well as to peptides derived from the conventional protein antigen, chicken
ovalbumin .
Here we demonstrate that first, Winked carbohydrate on the lateral surface of Va blocks the interaction of the TCR V(3 with the self superantigen, Mls-1', but has no effect on the TCR interaction with peptide antigen and MHC, second, that the interaction site for Mls-1' extends over the surface of the solvent-exposed /3-pleated sheet on the side of the TCR, and third, that mutations which affect both superantigen and peptide antigen reactivity lie at the beginning of the first complementarity determining region of VA consistent with models of . Recently, however, there have been several reports of T cell responses to certain antigens which are dictated primarily by the Vii element of the TCR (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) .
We have coined the term "superantigen" to describe these antigens (13) . (Table 1) , were identified in populations of wild mice and T cells bearing them were shown to be Mls-1, reactive (18) .
Site directed mutational analysis of the V08 .2a
gene from a non-Mls-reactive T cell hybridoma allowed identification of the variant residues expressed by the wild mice that were important for conferring Mls-la reactivity .
Since there is as yet no three dimensional structure available for the TCR, we interpreted the mutations we had generated using a model for TCR structure based on that of immunoglobulins (19) . The variant residues carried by the wild mouse V08
.2 elements that contributed to the interaction with Mls-1' are predicted to lie on a solvent-exposed a-pleated sheet of VO at a distance away from the CDRs that are thought to bind the complex of peptide and MHC . The conventional V#8.2a element has two potential sites for N-linked glycosylation and both of these sites were affected by the variant residues which led to Mls-1' reactivity of wild mouse T cells bearing the V08.2b and V08.2c alleles. The first aim of the present study was to determine whether carbohydrate on the solvent-exposed a-pleated sheet on the side of V08.2a might mask a V/3 interaction site for Mls-1' . Our data show that exposure of the /3-pleated sheet by loss of at least one glycosylation site is necessary, but not always sufficient, for Mls-1' interaction . The second aim of this study was to determine which other residues on the surface of the 0-pleated sheet contribute significantly to the Mls-1' interaction site . We found these residues to be distributed over the whole area of the exposed 0-pleated sheet .
Materials and Methods
Mice. All mice were purchased from' The Jackson Laboratory Bar Harbor, ME .
Cell Lines. Transfected T cell hybridomas expressing mutant Va8.2 elements were generated as previously described (17) . All the TCR mutants included in this study are shown in Table 1 . DO-11 .10.3 and DO-11.10.7 were used as transfection recipients. They are TCR chain loss-variants of the chicken ovalbumin specific T cell hybrid 21) .
Analysis of T Cell Markers. Expression of receptors on T cell hybridoma transfectants was assessed by immunofluorescent staining using a collection of anti-V#8 antibodies ; antiVO8.1+8 .2+8 .3, F23.1 (22) , antiV08.1+8 .2, KJ16 (23), antiV08.2a, F23.2 (22) , and the antibody specific for the idiotype of DO-11.10, KJ1 (24) . The transfectants were also analyzed for their expression of CD4 using GK1.5 (25) . In all cases biotinylated antibodies were used in conjunction with phycoerythrin-coupled avidin (Tago Inc., Burlingame, CA) as previously described (13) .
Stimulation Assays. Transfected T cell hybridomas were screened for Mls-1' reactivity by culturing 105 hybrid cells with 106 spleen cells from CBA/J (Mls-1'), (CBA/J x CBA/CaJ) Fl (Mls-1' 1) or CBA/CaJ (Mls-111) . Responses of the hybridomas to various doses of chicken ovalbumin peptide (cOVA)' 327-339 were assessed by culturing 105 hybrid T cells with 106 spleen cells from BALB/c (H-2d) or C57BL/10 (H-2b) . Stimulation by solid phase antiTCR mAbs provided controls for responsiveness of the hybrids. Microtiter wells were coated with 100 Ag/ml affinity-purified goat anti-rat IgG (H + L) (Jackson ImmunoResearch Inc., Avondale, PA) or 40 hg/ml protein A (Sigma Chemical Co., St . Louis, MO). Subsequently, the wells were washed thoroughly and incubated with KJ16 or GM5.777-containing supernatants. After further washing of the wells, 10 5 T cell hybrids were cultured per well . After 24 h the contents of the wells were assayed for lymphokine production using the HT-2 cell line (26) . Survival of HT-2 cells was assessed using 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyltetrazohwn bromide (MTT) (Sigma Chemical Co .) (27) .
Production ofthe GM5.777 Monoclonal Antibody. TCR from the T cell hybrid 2HB51.8 (28) was purified using an immunoaffinity column bearing a mAb (H28-710) specific for Ca (29 To determine the specificity of GM5.777, the antibody was used to stain a panel of T cell hybrids expressing different TCRs, derived from C57BL/10 (30) . GM5.777 reacted with the majority of hybrids generated with BW5147 (22/25), whereas it did not react with any of those generated using an a chain loss variant ofBW5147 (0/29) (31), suggesting that the antibody may be binding to an epitope present on the BW-derived Val-bearing chain or to a combinatorial determinant generated by the Veil and Vol chains contributed by BW Since GM5.777 did not bind significant numbers of peripheral T cells from AKR or C57BL/10 (data not shown), it is unlikely that the antibody is specific for Val elements.
Surface Labeling of Cells. Cell surface iodination of transfected T cell hybrids was performed by the chemical reaction catalyzed by Iodogen (Pierce Chemical Co., Rockford, IL) as previously described (32) . Cell lysates were subsequently prepared by detergent lysis in 1% NP-40 (32) and debris was removed by centrifugation at 12,000 g for 20 min.
Immunoprecipitation . To immunoprecipitate individual a and a chains of the TCR, the cell lysates were subjected to reduction and alkylation . The NP-40lysates were reduced with 0.05 M 2-ME for 1 h at 4°C and subsequently alkylated with 0.15 M iodoacetamide at pH 8, for 1 h. Under these conditions immunoprecipitation of the lysate with anti-O chain reagents results in the precipitation of fl chains only (RT Kubo, unpublished observations) .
N-Glycanase Treatment. Immunoprecipitates were washed in 0.1 M sodium phosphate buffer, pH 8.6, and were resuspended in this buffer containing 0.5% SDS, pH 8.6, and boiled for 3 min. After centrifugation the supernatant was removed and divided into two samples. The samples were adjusted to 1% NP-40 and 6 JAI 50% glycerol/2 .5 mM EDTA, with or without 1.5 U N-glycanase (Genzyme, Boston, MA), were added, as previously described (33) . After overnight incubation at 37°C, an equal volume of 2 x Laemmli sample buffer (34) was added to the samples before electrophoretic analysis on 11% SDS polyacrylamide gels under reducing conditions .
Results
In these studies on the effects of amino acid substitutions in V(3 on the specificity of T cells bearing a particular T cell receptor, we chose to use derivatives of the T cell hybridoma DO-11.10. DO-11.10 was created by fusion of a T cell specific for cOVA and IAd with the thymoma BW5147 (20) . DO-11 .10 reacts with c0VA/IAd, weakly with IAb and cOVA/IAb and does not react with WS-la. It expresses TCR chains bearing Va13 and V#8.2a, derived from the normal T cell parent, and Vat and VOL derived from BW5147 . Two derivatives were used in these experiments, DO-11.10.3, which has lost the gene encoding the Vf8 .2a-bearing (3 chain, and DO-11.10.7, which has lost this a chain gene and the gene encoding the Va13-bearing a chain (21) . The products of 0 chain genes transfected into DO-11. of the # chain genes transfected into DO-11 .10 .7 can only pair with the BW derived cx chain. These derivatives were transfected with genes encoding a chains with various mutations in V08.2 (Table 1 ) and the transfectants were examined for the properties and specificities of the TCRs thus generated .
Carbohydrate on Va8.2 Elements Blocks the Interaction of TCRs
with Mls-1°. We have previously reported a number of mutations that revealed amino acids important for conferring Mls-1' reactivity. The mutation 22N-D or the pair of mutations 70E-->K/71N-E conferred Mls-1' reactivity to the otherwise non-Mls-1'-reactive, V08 .2a-bearing, T cell hybrid, . Both mutations 22N-D and 71N-E destroyed potential glycosylation sites on the Vf8.2a element expressed by laboratory inbred mouse strains. To address whether glycosylation at one or both of these sites blocks a potential binding site for Mls-1' on V#8.2a we generated a panel of transfectants expressing mutant V08 .2 elements in which the potential glycosylation sites were destroyed. The consensus tripeptide sequence for an Winked glycosylation site is N X S/T (where X is any amino acid) : thus to prevent glycosylation these sites were altered by N-Q mutation or, alternatively, by S-A or T-" A mutation.
To determine whether the potential glycosylation sites on the Vf8.2 element were indeed glycosylated, the TCR chains from 11 25 surface-labeled hybrids expressing transfected normal or mutant (3 genes were analyzed . The cells were surface labeled and lysed as described in the Materials and Methods. Reduction and alkylation of the lysates resulted in the dissociation of the cx and 0 chains of the TCR such that subsequent immunoprecipitation using mAbs specific for the (3 chain resulted in only a chains in the immunoprecipitate (RT Kubo, unpublished observation) .
The results of the F23.1 immunoprecipitation for four transfected hybrids are shown in Fig. 2 A . The mutant a chains 22N--" Q and 71N-Q ran with slightly higher mol wt than the mutant a chain 22N-D/70E-K/71N-E (compare lanes 2 and 3 with 4) that had no potential VO glycosylation sites, indicating that N-linked carbohydrate could be present on residues 71 or 22 . If both of the potential glycosylation sites on the V08.2a element were glycosylated, then the molecular mass of the wild type V,38 .2a-bearing /3 chain would be expected to be greater than that of mutant,l3 chains 22N--Q or 71N-+Q, however this was not seen to be the case (compare lane 1 with lanes 2 and 3, Fig. 2 A) . The V08.2a 0 chain ran as a broad band with a molecular mass of about After N-glycanase treatment the /3 chains from all four hybrids ran with the same molecular mass of ti32 kD (lanes S-8), indicating that the mutations had not affected the mobility of the polypeptide chains. The drop in molecular mass from the untreated mutant (3 chain 22N-+D/70E-K/71N--> CE to the N-glycanase-treated bands (compare lane 4 with lanes 5-8) is due to the presence of three Winked carbohydate moieties on C/3 (35) .
Transfected hybridomas were matched for their levels of expression of the mutant gene products using the antiidio- 
-, 5 10 IL-2 U/ml . All transfectants responded to KJ16-stimulation by generating X640 IL-2 U/ml . typic antibody, KJl (24), which will detect Va13/V/38.2+ TCRs, or the anti V(38 antibody, F23.1 (22) , which will detect Va8.2+ a chains paired with any a chain. The DO-11 .10.3 transfectants all had high levels of the accessory molecule CD4 while the DO-11.10.7 transfectants all had low levels of CD4 (17) . These transfectants were all tested for their ability to respond to Mls-la presented by CBA/J spleen cells. The DO-11.10.3 transfectant expressing mutation 22N--,Q (which prevented glycosylation at position 22) responded to Mls-1' stimulation, while the DO-11.10.7 transfectant expressing the same mutation did not (Table 2) . This result was reminiscent of our previous finding that DO-11 .10.3/22N-D was Mls-la reactive whilst DO-11.10.7/ 22N-"D was not (17) . It is possible that these mutant V(38 .2 chains impart Mls-1' reactivity when they pair with the WO-containing but not with the Vac1-containing a chain, or alternatively, it may be that the mutant receptor is sufficient to confer Mls-la reactivity only in the presence of high levels of the accessory molecule CD4 . These results suggest that prevention of Winked glycosylation by mutations 22N-D and 22N-Q facilitates the interaction of the V08 .2-containing TCR with Mls-la .
Neither of the transfectants expressing mutation 24T-A responded to Mls-1a stimulation ( Table 2 ), suggesting that prevention of glycosylation at position 22 was alone insufficient to confer Mls-reactivity and that 24T may be critical for this reactivity. This possibility is addressed in more detail below.
Mutations 71N-Q and 73S-A also did not confer Mls-1a reactivity ( Table 2 ), demonstrating that prevention of glycosylation at position 71 was not sufficient to confer Mls-1' reactivity on V08.2a . However, the analysis of more mutations designed to determine exactly which residue(s) carried by the variant Va8.2c allele contribute to its Mls-1a-reactivity suggested that preventing glycosylation at position 71 was necessary to unmask a potential interaction site for Mls-1a on this V/3.
In our previous study we determined that the pair of mutations 70E-K/71N-E, carried by the variant V08.2c allele, conferred Mls-1a reactivity upon both DO-11 .10 .3 and DO-11 .10 .7 transfectants (17) . These mutations would, of course, remove the Winked glycosylation site at position 71 and also introduce a charge change at position 70 . To test which of these changes was required to confer Mls-1a-reactivity on V08.2-bearing T cells we generated transfectants expressing these mutations singly. In addition we also produced a transfectant which carried the pair of mutations 70E-K/73S-A . This V/3 element had the positively charged lysine residue at position 70 and could not be glycosylated at the adjacent asparagine residue since the consensus sequence had been altered . The reactivity patterns for these hybridomas are shown in Fig. 3 . Alone, neither of the charged residues at 70 or 71 conferred Mls-1a reactivity, however mutant 70E-"K/73S-A was reactive. This suggested that it was necessary to prevent glycosylation at position 71 in order to facilitate the interaction of Mls-la with the positively charged lysine at position 70 . Further, the magnitude of the response of mutant 70E-"K/73S-" A was reproducibly twofold lower than that of mutant 70E-K/71N->E, implying 118 7 Pullen et al.
that either 71E or 73S may also facilitate the interaction with Mls-1a .
Addition of Novel Glycosylation Sites in V08 .2b Reduces
Mls-Id Reactivity. In light of our findings that Winked carbohydrate at position 22 masked an interaction site for Mls-1a on V08.2a, and that carbohydrate at position 71 prevented the interaction of the lysine residue carried by the V08.2c allele with Mls-1a, we investigated the effect of introducing new potential glycosylation sites elsewhere on the solvent exposed a-pleated sheet of V08 .2b. DO-11.10 .3 transfectants carrying the V08.2b allele (mutant 22N--,D), had previously been generated and shown to be Mls-la reactive (17) . Asparagine residues were substituted at positions 16 or 18 in V08.2b to introduce novel potential Winked glycosylation sites . VO1 is glycosylated at position 18, whilst none of the known VO elements have a potential glycosylation site at position 16. SDS-PAGE analysis of F23 .1 immunoprecipitated /3 chains from Ills surface-labeled transfectants bearing these mutant R chains (Fig . 2 B) showed that mutant a chains 16K-N/22N-"D and 18T->N/22N-D had higher molecular masses than the V,68 .2b-bearing (3 chain (mutant 22N-D) (compare lanes 2 and 3 with lane 1), indicating that Winked glycosylation did indeed occur at these novel sites.
These transfectants expressing mutant Va8 .2 elements with Winked carbohydrate present at position 71 and either position 16 or position 18 were screened for Mls-1a reactivity, using CBA/J spleen cells as stimulators . They showed diminished responses compared to mutant 22N-D (Fig. 4) , that is only glycosylated at position 71. To assess further this reduction in Mls-1a responsiveness, in subsequent experiments (CBA/J x CBA/CaJ)F1 spleen cells were also included as stimulators . These stimulators were heterozygous for Mls-1a and so are predicted to express half the level of the stimulatory ligand . As shown in Fig. 4 the mutants with novel glycosylation at positions 16 or 18 did not respond to the Fl spleen cells, confirming their reduced responsiveness to Mls-1'.
In general the TCR mutations generated in this study did not grossly alter the conformation of the TCR as judged by the staining profiles with monoclonal antibodies F23.1 and F23 .2, which react with TCRs including all V#8s or V08.2a, (Fig.  4) , suggesting that KJ16 did bind weakly to the mutant TCR.
The Mls-1°Interaction Site on V08.2 Extends Over the Solvent-Exposed (3-Pleated Sheet On the Side of the TCR . To determine the extent of the Mls-1a interaction site on the solvent-exposed /3-pleated sheet on the side of the TCR, mutations were introduced into Mls-1a reactive Vf8.2 elements which we had already generated. Transfectants expressing these mutant Vos were then analyzed for Mls-reactivity. Loss of Mls-11 reactivity would suggest that the mutated residues were critical for the interaction with Mls-1a .
Instead of introducing random mutations in the V(3 elements, the available sequences of V/3 elements were compared for residues that are conserved among Mls-11 reactive Vas but that are substituted in non-Mls-reactive V(3s. Three amino acids stood out as being possible contributors to the Mls-1a interaction site : 65S and 73S are present in all inbred mouse strain Vls known to be Mls-11 reactive (Vf s 6, 7, 8.1, and 9) (4, 5, 9-12), and 7211 is present in Vos 6, 7, and 8.1 . Few of the non-Mls-reactive Vf elements carry these residues at these positions. We introduced mutations 65S-V, 7211-S, or 73S-1 into the Vl8 .2 mutant element already known to confer strong Mls-1a reactivity, mutant 70E-K/71N-E. In the hope that the TCR would maintain its gross structure in spite of these additional mutations, the residues chosen for substitution occurred in at least one other V(3 element.
For example, 72S is present in Vos 5.1, 5 .2, 11, 12, 13, and 15 . As shown in Fig. 5 none of these mutations reduced the magnitude of the response to CBA/J stimulator cells, demonstrating that none of these residues appeared critical for the Mls-11 reactivity of this particular Va8.2 element.
Residues 16K, 17V, 18T, and 24T are present in at least two of the Mls-la-reactive Va elements, and therefore mutations of these residues were introduced into the previously generated Mls-la-reactive V08.2b element (mutant 22N-D) . Mutation 16K-A had no effect on the Mls-l a reactivity of the V08.2b element. However, mutation 24T-Y, or the pair of mutations 17V--"S/18T-V, were sufficient to prevent Mls-11 reactivity (Fig. 6) , indicating that 24T, and 17V, or 18T are critical for Mls-11 reactivity of V08.2b.
Thus, residues 17 or 18, and 24, as well as residues 22, 70, and 71, contribute to Mls-la reactivity of V08.2-bearing TCRs. All these residues lie on the solvent-exposed 0-pleated sheet on the side of the TCR (Fig. 1) .
Mutations at Position 24 Alter Reactivity to Peptide Antigen-'HC . that the TCR structure was not grossly distorted by the 24T-Y or 17V-S/18T-V mutations (data not shown) .
To assess the effect of these mutations upon the interaction of the TCR with class II, the responses of the transfectants to peptides of the conventional protein antigen COVA were measured . There were no shifts in the dose response curves for any of the mutant TCRs when the cOVA peptide 327-339 was presented by the IAd molecule (Fig. 7 A and data not shown), suggesting that none of the mutations caused major perturbation of the TCR interaction with this class II molecule.
The measurement of the cross-reactive response of the transfectants to cOVA peptides presented by IAb was hindered by a weak background response in the absence of added cOVA peptide. This response to IAb is contributed by TCRs composed of the BWderived Vat-containing a chain and the V08 .2-containing /3 chain (21). Inclusion of supernatant containing mAb GM5 .777 in the stimulation cultures blocked this weak anti-IAb response ( Table 3 ), confirming that the antibody specificity was indeed for an epitope on the Valbearing a chain of BW The use of this antibody facilitated the assessment of the response of the transfectants to added peptides, and indeed it may prove useful in dissecting the reactivities of other hybrids generated using the T cell fusion partner, BW5147 .
Mutation 24T-Y caused at least a 100-fold shift in the dose response curve to the cOVA peptide presented by IAb (Fig. 7 B) . Transfectants expressing the 24T-A mutation, that had been generated to investigate the role of glycosylation at position 22, also showed a diminished response (at least 10-fold) to cOVA peptides presented by IAb (Fig. 7 B) . These data suggest that mutations at position 24 perturb the interaction of the TCR with the IAb molecule. The loss of Mls-1a reactivity of Va8.2b due to mutation 24T--"Y (Fig.  6 ) may therefore be due the disruption of the TCR/class II interaction during the presentation of Mls-1a .
The paired mutations 17V-S/18T-V did not affect the response to cOVA peptide presented by IAb (data not shown), although they ablated the response to Mls-1a (Fig.  6 ) . This suggests that these mutations disrupt the interaction of the TCR with Mls-1a, and not the interaction of the TCR with MHC. This paper concerns the structure of the trimolecular complex formed between TCRs, class II MHC proteins and the self superantigen, Mls-la . The structures of two of the components of the complex, TCR and class II, have been modeled on the known structures of immunoglobulin and class I MHC, respectively, and there is some evidence to support the conclusions thus drawn (19, (36) (37) (38) (39) . Until very recently, the molecular nature of Mls-12 was unknown . We have just shown, however, that another mouse self superantigen is encoded by a mouse mammary tumor virus (reference 40 and Y Choi, J .W. Kappler, and P Marrack, manuscript in preparation) and it is likely that Mls-12 and other self superantigens will be closely related. The complex studied in this paper is therefore formed between three proteins, two of which are known to be globular in nature.
Models of the TCR based on the structure of immunoglobulin suggest that a solvent-exposed lateral surface of the molecule is formed by a /3-pleated sheet made up of amino acids of VA This surface is predicted to be well away from the residues in the CDRs, thought to contact antigenic peptides and MHC, and is also well away from the contact region between Va and Vf. Recent experiments have suggested that it is this face of V)3 that binds superantigens (17, 41, 42) . We showed that mutant forms of Vf8 .2 found in wild mice probably engage Mls-12 with amino acids in this face (17) . Variant forms of V017a isolated from wild mice by Cazenave et al . (41) had lost the ability to react with a mouse superantigen plus IE, and one of the amino acids contributing to the loss would also lie on the exposed /3-pleated sheet of V/3, at position 71 by the numbering system used in this paper.
Other studies on receptor-ligand interactions indicate that protein-protein interactions often occur over fairly large surfaces, with contact points formed between many amino acids on either protein (43, 44) . The experiments reported here suggest that this is also true for the interaction between V08.2 and Mls-1a . For example, the presence of a lysine at position 70 . of Va8.2 conferred Mls-la reactivity upon T cells bearing it, providing an adjacent glycosylation site had also been destroyed. Valine 17 and/or threonine 18 contributed to the Mls-12 reactivity of this variant Vii and our results also in-IL-2 production in response to IAb stimulation Antibody present
dicated that a glutaminic acid at position 71 or a serine residue at 73 might also enhance binding of the same variant . As illustrated in Fig. 1 , these residues are predicted to lie quite far apart on the solvent-exposed 0-pleated side of V16 The data also suggested that although V#8.2 and Mls-1a could interact over a large area, it was not always essential that residues over the whole area be engaged. In some mutants one part of the f3-pleated sheet on the side of Vf3 contributed to binding, in other mutants a different part of the sheet was more important . T cells bearing V#8 .2 that lack the glycosylation site at position 22 could react with Mls-la even though the 6 chain did not bear a lysine at position 70 . In the presence of glycosylation at position 22 however, the absence of glycosylation at position 71 and a lysine at position 70 were required for Mls-la reactivity.
It is likely that the mutations introduced at these positions affected Mls-1a reactivity because of direct effects on the binding of Vf38 .2 to Mls-1', rather than because of gross distortions of the TCR . The products of all these mutations continued to react normally with°OVA/IAd and moreover also continued to react well with at least three of four monoclonal anti-V# antibodies.
Mutations in several of the amino acids which lie on the solvent-exposed 0-pleated sheet of VA, that are conserved in Vos known to react with Mls-1a (65S, 72F, and 73S), did not affect reactivity in these experiments . Perhaps the changes chosen were not disruptive enough: for example, no charge changes were introduced by any of these mutations .
Among the most striking findings in these and our previous studies were the discoveries that the interaction site on V0 for self superantigens lies on the side of V0 and that it can be masked by Winked carbohydrates . The finding that Winked carbohydrate may conceal a potential binding site is relatively novel . However, evolutionarily, such a strategy offers the advantage that a relatively large binding site on the side of Vf3 can be masked or revealed by a single amino acid mutation. Interpretation of these experiments is ham-1190 pered, however, by lack of detailed knowledge about the structure of carbohydrates lying on protein faces . For example, it is not known whether carbohydrates can lie in several alternate configurations on the protein surface, nor whether they can be easily displaced by ligands binding to part of the surface they normally cover.
Choi et al. (42) have shown that the foreign superantigens, the Staphylococcal enterotoxins (SEs), bind to the same face of TCR V0 as Us-la . Therefore we analyzed the panel of T cell hybridomas generated for the studies in this paper for reactivity with SEs plus IA or IE . T cells bearing Vf8 .2 normally respond to SEB, SECT, SEC2, and SEC3 . None of the mutations in Vf3 described here affected responses to these toxins, with one exception . Mutation 72F-S caused a reproducible 10-fold reduction in the response of T cells bearing it to SEC1 presented by both IA or IE, but had no effect on responsiveness to the closely related SE, SEC2 (data not shown) . We were surprised that none of the residues mutated was absolutely required for interaction with the toxins . Although the interactions sites on Vf3 for self and foreign superantigens may be overlapping it is possible that the SEs bind with higher affinity than Mls-1a to TCR V# and several mutations may therefore be required in combination to perturb the TCR/SE interactions.
Finally, these results confirm the idea that superantigens and conventional antigens bind at nonoverlapping sites on the TCR VO (45, 46) . A number of other studies have lead to the same conclusion for superantigen and conventional peptide-antigen binding to class II molecules. Herman et al . (47) , for example, showed that amino acid residues lying outside the presumed antigenic peptide-binding pocket of HLA-DR 0 chains could affect the binding and presentation of foreign superantigens, the SEs, to T cells. Likewise, Dellabona et al . (48, 49) have shown that mutations in the a-helical region of class II a chains can affect presentation of antigenic peptides, but not SEB, to T cells. 
